Toronto - Delayed Quote CAD

Microbix Biosystems Inc. (MBX.TO)

0.3600
0.0000
(0.00%)
At close: May 14 at 3:02:34 PM EDT
Advanced Chart
Loading Chart for MBX.TO
  • Previous Close 0.3600
  • Open 0.3750
  • Bid 0.3550 x --
  • Ask 0.3650 x --
  • Day's Range 0.3600 - 0.3750
  • 52 Week Range 0.2900 - 0.5500
  • Volume 40,373
  • Avg. Volume 117,978
  • Market Cap (intraday) 50.989M
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) 36.00
  • EPS (TTM) 0.0100
  • Earnings Date May 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 2, 1999
  • 1y Target Est 0.80

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

www.microbix.com

--

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Microbix Biosystems Inc.

Recent News: MBX.TO

View More
View More

Performance Overview: MBX.TO

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MBX.TO
12.20%
S&P/TSX Composite index (^GSPTSE)
4.35%

1-Year Return

MBX.TO
12.50%
S&P/TSX Composite index (^GSPTSE)
15.51%

3-Year Return

MBX.TO
23.40%
S&P/TSX Composite index (^GSPTSE)
27.82%

5-Year Return

MBX.TO
5.88%
S&P/TSX Composite index (^GSPTSE)
77.07%

Compare To: MBX.TO

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MBX.TO
Microbix Biosystems Inc.
0.3600
0.00%
Mkt Cap CAD 50.989M
Industry Biotechnology
RVX.TO
Resverlogix Corp.
0.0400
-11.11%
Mkt Cap CAD 11.226M
Industry Biotechnology
COV.V
Covalon Technologies Ltd.
2.5300
-4.17%
Mkt Cap CAD 69.368M
Industry Biotechnology
TRP.AX
Tissue Repair Ltd
0.1900
-2.56%
Mkt Cap AUD 11.488M
Industry Biotechnology
ILA.AX
Island Pharmaceuticals Limited
0.1800
0.00%
Mkt Cap AUD 37.847M
Industry Biotechnology
MDNA.TO
Medicenna Therapeutics Corp.
1.0500
-4.55%
Mkt Cap CAD 82.126M
Industry Biotechnology
PHRM.CN
PharmaTher Holdings Ltd.
0.2300
0.00%
Mkt Cap CAD 20.359M
Industry Biotechnology
TYP.AX
TRYPTAMINE FPO [TYP]
0.0380
+2.70%
Mkt Cap AUD 54.679M
Industry Biotechnology
BCT.TO
BriaCell Therapeutics Corp.
4.2400
-4.72%
Mkt Cap CAD 28.731M
Industry Biotechnology
DTC.CN
Defence Therapeutics Inc.
0.9500
0.00%
Mkt Cap CAD 51.989M
Industry Biotechnology
APS.TO
Aptose Biosciences Inc.
2.3500
-7.48%
Mkt Cap CAD 5.998M
Industry Biotechnology

Statistics: MBX.TO

View More

Valuation Measures

As of 5/14/2025

  • Market Cap

    50.99M

  • Enterprise Value

    44.38M

  • Trailing P/E

    25.71

  • Forward P/E

    35.97

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.15

  • Price/Book (mrq)

    1.76

  • Enterprise Value/Revenue

    1.93

  • Enterprise Value/EBITDA

    9.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.35%

  • Return on Assets (ttm)

    3.79%

  • Return on Equity (ttm)

    6.85%

  • Revenue (ttm)

    23.03M

  • Net Income Avi to Common (ttm)

    1.92M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.05M

  • Total Debt/Equity (mrq)

    22.29%

  • Levered Free Cash Flow (ttm)

    566.28k

View More

Research Analysis: MBX.TO

View More
View More

People Also Watch

HBP.TO Helix BioPharma Corp.
0.9600
0.00%
 
ONC.TO Oncolytics Biotech Inc.
0.7100
-1.39%
 
RVX.TO Resverlogix Corp.
0.0400
-11.11%
 
TH.TO Theratechnologies Inc.
3.5100
-3.84%
 
EDT.TO Spectral Medical Inc.
0.8100
-3.57%
 
BYL.TO Baylin Technologies Inc.
0.2600
-3.70%
 
APS.TO Aptose Biosciences Inc.
2.3500
-7.48%
 
CPH.TO Cipher Pharmaceuticals Inc.
12.47
-2.43%
 
MIR.V MedMira Inc.
0.0800
-5.88%
 
MDNA.TO Medicenna Therapeutics Corp.
1.0500
-4.55%
 
GSI.V Gatekeeper Systems Inc.
0.5200
+10.64%
 
VPT.V Ventripoint Diagnostics Ltd.
0.1200
-7.69%
 
CRRX.TO CareRx Corporation
2.7700
-0.36%
 
GUD.TO Knight Therapeutics Inc.
5.78
-0.52%
 
COV.V Covalon Technologies Ltd.
2.5300
-4.17%
 
BU.TO Burcon NutraScience Corporation
0.1000
-4.76%